Literature DB >> 21514093

Hydrocortisone at stress-associated concentrations helps maintain human heart rate variability during subsequent endotoxin challenge.

Athos J Rassias1, Paul M Guyre, Mark P Yeager.   

Abstract

PURPOSE: We evaluated the differential impact of stress-associated vs high pharmacologic concentrations of hydrocortisone pretreatment on heart rate variability (HRV) during a subsequent systemic inflammatory stimulus.
MATERIALS AND METHODS: Healthy volunteers were randomized to receive placebo (Control) and hydrocortisone at 1.5 μg/kg per minute (STRESS) or at 3.0 μg/kg per minute (PHARM) as a 6-hour infusion. The STRESS dose was chosen to replicate the condition of physiologic adrenal cortical output during acute systemic stress. The PHARM dose was chosen to induce a supraphysiologic concentration of cortisol. The next day, all subjects received 2 ng/kg Escherichia coli endotoxin (lipopolysaccharide). Heart rate variability was analyzed with the statistic approximate entropy (ApEn). A lower ApEn correlates with decreased HRV.
RESULTS: At the 3-hour nadir, the decrease in ApEn in the STRESS group was significantly less compared to placebo (P < .03), whereas ApEn in the PHARM group was not statistically different. We also found that the maximal decrease in ApEn preceded maximal increase in heart rate in all groups. The decrease in R-R interval was maximal at 4 hours, whereas the ApEn nadir was 1 hour earlier at 3 hours.
CONCLUSIONS: Pretreatment with a stress dose of hydrocortisone but not a higher pharmacologic dose maintained a significantly higher ApEn after endotoxin exposure when compared to a placebo. In addition, decreases in ApEn preceded increases in heart rate.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21514093      PMCID: PMC3782856          DOI: 10.1016/j.jcrc.2011.01.009

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  31 in total

1.  Heart rate variability and infection: diagnosis, prognosis, and prediction.

Authors:  Andrew J E Seely
Journal:  J Crit Care       Date:  2006-09       Impact factor: 3.425

2.  Pre-operative measurement of heart rate variability predicts hypotension during general anesthesia.

Authors:  C-J Huang; C-H Kuok; T B J Kuo; Y-W Hsu; P-S Tsai
Journal:  Acta Anaesthesiol Scand       Date:  2006-05       Impact factor: 2.105

3.  Autonomic dysfunction predicts mortality in patients with multiple organ dysfunction syndrome of different age groups.

Authors:  Hendrik Schmidt; Ursula Müller-Werdan; Thomas Hoffmann; Darrel P Francis; Massimo F Piepoli; Mathias Rauchhaus; Roland Prondzinsky; Harald Loppnow; Michael Buerke; Dirk Hoyer; Karl Werdan
Journal:  Crit Care Med       Date:  2005-09       Impact factor: 7.598

4.  Heart rate variability-guided prophylactic treatment of severe hypotension after subarachnoid block for elective cesarean delivery.

Authors:  Robert Hanss; Berthold Bein; Helga Francksen; Wiebke Scherkl; Martin Bauer; Volker Doerges; Markus Steinfath; Jens Scholz; Peter H Tonner
Journal:  Anesthesiology       Date:  2006-04       Impact factor: 7.892

5.  Heart rate characteristics: novel physiomarkers to predict neonatal infection and death.

Authors:  M Pamela Griffin; Douglas E Lake; Eric A Bissonette; Frank E Harrell; T Michael O'Shea; J Randall Moorman
Journal:  Pediatrics       Date:  2005-11       Impact factor: 7.124

6.  Decreased physiologic variability as a generalized response to human endotoxemia.

Authors:  Athos J Rassias; Peter T Holzberger; Alice L Givan; Scott L Fahrner; Mark P Yeager
Journal:  Crit Care Med       Date:  2005-03       Impact factor: 7.598

7.  Heart rate variability measures as predictors of in-hospital mortality in ED patients with sepsis.

Authors:  Wei-Lung Chen; Jiann-Hwa Chen; Chien-Cheng Huang; Cheng-Deng Kuo; Chun-I Huang; Liang-Shong Lee
Journal:  Am J Emerg Med       Date:  2008-05       Impact factor: 2.469

8.  Hydrocortisone effects on cardiovascular variability in septic shock: a spectral analysis approach.

Authors:  Jerome Aboab; Andrea Polito; David Orlikowski; Tarek Sharshar; Muriel Castel; Djillali Annane
Journal:  Crit Care Med       Date:  2008-05       Impact factor: 7.598

Review 9.  The role of heart rate variability in risk stratification for adverse postoperative cardiac events.

Authors:  Timo Laitio; Jouko Jalonen; Tom Kuusela; Harry Scheinin
Journal:  Anesth Analg       Date:  2007-12       Impact factor: 5.108

10.  Hydrocortisone therapy for patients with septic shock.

Authors:  Charles L Sprung; Djillali Annane; Didier Keh; Rui Moreno; Mervyn Singer; Klaus Freivogel; Yoram G Weiss; Julie Benbenishty; Armin Kalenka; Helmuth Forst; Pierre-Francois Laterre; Konrad Reinhart; Brian H Cuthbertson; Didier Payen; Josef Briegel
Journal:  N Engl J Med       Date:  2008-01-10       Impact factor: 91.245

View more
  4 in total

1.  On heart rate variability and autonomic activity in homeostasis and in systemic inflammation.

Authors:  Jeremy D Scheff; Benjamin Griffel; Siobhan A Corbett; Steve E Calvano; Ioannis P Androulakis
Journal:  Math Biosci       Date:  2014-03-26       Impact factor: 2.144

2.  Modeling physiologic variability in human endotoxemia.

Authors:  Jeremy D Scheff; Panteleimon D Mavroudis; Panagiota T Foteinou; Steve E Calvano; Ioannis P Androulakis
Journal:  Crit Rev Biomed Eng       Date:  2012

Review 3.  Translational applications of evaluating physiologic variability in human endotoxemia.

Authors:  Jeremy D Scheff; Panteleimon D Mavroudis; Steve E Calvano; Ioannis P Androulakis
Journal:  J Clin Monit Comput       Date:  2012-12-01       Impact factor: 2.502

4.  Acute hydrocortisone administration reduces cardiovagal baroreflex sensitivity and heart rate variability in young men.

Authors:  Ahmed M Adlan; Jet J C S Veldhuijzen van Zanten; Gregory Y H Lip; Julian F R Paton; George D Kitas; James P Fisher
Journal:  J Physiol       Date:  2018-09-12       Impact factor: 5.182

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.